Mustang Bio Inc (MBIO) Stock Analysis

Mustang Bio Inc (MBIO) is a publicly traded company in the HEALTHCARE sector. It trades at $0.77, carries a market capitalization of $5.83M. This page summarizes the public market data, fundamentals, and frequently asked questions for MBIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Mustang Bio Inc currently has a Neutral sentiment score of 0.10.

About Mustang Bio Inc

Mustang Bio, Inc. (ticker: MBIO) is a clinical-stage biopharmaceutical company headquartered in Worcester, Massachusetts, focused on pioneering cell and gene therapies for hematologic cancers, solid tumors, and rare genetic disorders. The company boasts a promising pipeline and utilizes advanced technologies aimed at revolutionizing treatment options, striving for potentially curative outcomes for patients. With its strong commitment to innovation in gene editing and strategic collaborations,...

GNG Research Analysis

GNG Research scores Mustang Bio Inc (MBIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MBIO.

Frequently Asked Questions

Does MBIO pay dividends?

Mustang Bio Inc (MBIO) does not currently pay a regular dividend.

What is MBIO's market cap?

Mustang Bio Inc (MBIO) has a market capitalization of $5.83M with a current stock price of $0.77.